Michael Bui

Mr. Michael Bui

Health Technology and Services Research, University of Twente, Enschede, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2023 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
Michael BuiMichael Bui
Michael Bui
WNWieke S. Nijmeijer
Wieke S. Nijmeijer
JHJohannes H. Hegeman
Johannes H. Hegeman
AWAnnemieke Witteveen
Annemieke Witteveen
CGCatharina G. M. Groothuis-Oudshoorn
Catharina G. M. Groothuis-Oudshoorn
Hip fractures are a global health problem with a high postoperative mortality rate. Preoperative predictors for early mortality could be used to optimise and personalise healthcare strategies. This study aimed to identify predictors for early mortality following hip fracture surgery. Cohort studies examining independent preoperative predictors for mortality following hip fracture surgery were identified through a systematic search on Scopus and PubMed. Predictors for 30-day mortality were the primary outcome, and predictors for mortality within 1 year were secondary outcomes. Primary outcomes were analysed with random-effects meta-analyses. Confidence in the cumulative evidence was assessed using the GRADE criteria. Secondary outcomes were synthesised narratively. Thirty-three cohort studies involving 462,699 patients were meta-analysed. Five high-quality evidence predictors for 30-day mortality were identified: age per year (OR: 1.06, 95% CI: 1.04–1.07), ASA score ≥ 3 (OR: 2.69, 95% CI: 2.12–3.42), male gender (OR: 2.00, 95% CI: 1.85–2.18), institutional residence (OR: 1.81, 95% CI: 1.31–2.49), and metastatic cancer (OR: 2.83, 95% CI: 2.58–3.10). Additionally, six moderate-quality evidence predictors were identified: chronic renal failure, dementia, diabetes, low haemoglobin, heart failures, and a history of any malignancy. Weak evidence was found for non-metastatic cancer. This review found relevant preoperative predictors which could be used to identify patients who are at high risk of 30-day mortality following hip fracture surgery. For some predictors, the prognostic value could be increased by further subcategorising the conditions by severity.

21 May 2025 in PharmacoEconomics
Verified
Journal Article
Open access
SNSven Petrus Henricus Nouwens
Sven Petrus Henricus Nouwens
SMStella Maria Marceta
Stella Maria Marceta
Michael BuiMichael Bui
Michael Bui
DDDaisy Maria Alberta Hendrika van Dijk
Daisy Maria Alberta Hendrika van Dijk
CGCatharina Gerarda Maria Groothuis-Oudshoorn
Catharina Gerarda Maria Groothuis-Oudshoorn
EBEsther Wilhelmina de Bekker-Grob
Esther Wilhelmina de Bekker-Grob
Stakeholder preference evaluations are increasingly emphasized in healthcare policy and health technology assessment. Discrete choice experiments (DCEs) are the most common method for quantifying preferences among patients, the public, and healthcare professionals. While prior reviews (1990-2017) have examined DCE trends, no comprehensive synthesis exists for studies published since 2018. This updated review (2018-2023) provides critical insights into evolving methodologies and global trends in health-related DCEs. A systematic search (2018-2023) of Medline, Embase, and Web of Science identified relevant studies. Studies were screened for inclusion and data were extracted, including details on DCE design and analysis. To enable trend comparisons, the search strategy and extraction items aligned with previous reviews. Of 2663 identified papers, 1279 met the inclusion criteria, reflecting a significant rise in published DCEs over time. DCEs were conducted globally, with a remarkable increase in publications from Asia and Africa compared with previous reviews. Experimental designs and econometric models have advanced, continuing prior trends. Notably, most recent DCEs were administered online. The rapid growth of DCE applications underscores their importance in health research. While the methodology is advancing rapidly, it is crucial that researchers provide full transparency in reporting their methods, particularly in detailing experimental designs and validity tests, which are too often overlooked. Key recommendations include improving reporting of experimental designs, applying validity tests, following good practices for presenting benefit-risk attributes, and adopting open science practices. Ensuring methodological rigor will maximize the impact and reproducibility of DCE research in health economics.

3 September 2023
Verified
Conference Paper
Open access
Michael BuiMichael Bui
Michael Bui
KOKira Oberschmidt
Kira Oberschmidt
CGChristiane Grünloh
Christiane Grünloh
This paper introduces patient journey value mapping – an approach to capture experiences, emotions and values implicated in patients’ care delivery. As patients’ values (i.e., what’s important to them in their lives) may change along their patient journeys, our approach aims to support designers to respond to patients’ changing needs in the (re)design of eHealth, by mapping patients’ values and their prioritisations over time. To substantiate the creation of the map, we propose two preceding data collection phases comprising complementary empirical methods. First, important care-related events and associated values are collected retrospectively through interviews, and in-situ through diary studies. Subsequently, the data are analysed to develop materials to elicit values and value tensions through deepening discussions in an interactive workshop based on which the maps are finalised. The approach is illustrated through discussions and reflections on its application in a case study investigating patient values in eHealth for rehabilitation care.

11 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Michael BuiMichael Bui
Michael Bui
CGCatharina G. M. Groothuis-Oudshoorn
Catharina G. M. Groothuis-Oudshoorn
AWAnnemieke Witteveen
Annemieke Witteveen
JHJohannes H. Hegeman
Johannes H. Hegeman
Background: For hip fracture patients with a limited life expectancy, operative and palliative non-operative management (P-NOM) can yield similar quality of life outcomes. However, evidence on when to abstain from surgery is lacking. The aim of this study was to quantify the influence of patient characteristics on surgeons’ decisions to recommend P-NOM. Methods: Dutch surgical residents and orthopaedic trauma surgeons were enrolled in a conjoint analysis and structured expert judgement (SEJ). The participants assessed 16 patient cases comprising 10 clinically relevant characteristics. For each case, they recommended either surgery or P-NOM and estimated the 30-day postoperative mortality risk. Treatment recommendations were analysed using Bayesian logistic regression, and perceived risks were pooled with equal and performance-based weights using Cooke’s Classical Model. Results: The conjoint analysis and SEJ were completed by 14 and 9 participants, respectively. Participants were more likely to recommend P-NOM to patients with metastatic carcinomas (OR: 4.42, CrI: 2.14–8.95), severe heart failure (OR: 4.05, CrI: 1.89–8.29), end-stage renal failure (OR: 3.54, CrI: 1.76–7.35) and dementia (OR: 3.35, CrI: 1.70–7.06). The patient receiving the most P-NOM recommendations (12/14) had a pooled perceived risk of 30-day mortality between 50.8 and 62.7%. Conclusions: Overall, comorbidities had the strongest influence on participants’ decisions to recommend P-NOM. Nevertheless, practice variation and heterogeneity in risk perceptions were substantial. Hence, more decision support for considering P-NOM is needed.

16 December 2024 in BMJ
Verified
Journal Article
Closed access
SDSanne H B van Dijk
Sanne H B van Dijk
Michael BuiMichael Bui
Michael Bui
AEAnouk H Eijkelboom
Anouk H Eijkelboom

20 December 2024
Verified
Book Chapter
Closed access
PDF file
KOKira Oberschmidt
Kira Oberschmidt
CGChristiane Grünloh
Christiane Grünloh
MBMarijke Broekhuis
Marijke Broekhuis
Michael BuiMichael Bui
Michael Bui
MTMonique Tabak
Monique Tabak